There’s a need for better paediatric medicines as young citizens represent 100 % of the future of a healthy world.
In Europe 44 products have been authorized for forms of cancer that affect (also) children; 13 of these are approved for use in children.
It generally takes 12-15 years and cost more than 2 billion EUR to develop a new drug + the development time has been increasing over the years.
In the meantime off-label products are used to treat patients in urgent need of medicines. These are manufactured by talented hospital pharmacists. Our MiniLab technology is used to ensure compliant, safe and effective manufacture of personalized medicines in pharmacies.
CurifyLabs is attending the 4th Nordic Conference on Paediatric Medicines in Helsinki.